These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


89 related items for PubMed ID: 19885597

  • 1. Depletion of PI3K p85alpha induces cell cycle arrest and apoptosis in colorectal cancer cells.
    Sun Y, Zhao S, Tian H, Xie X, Xiao F, Li K, Song Y.
    Oncol Rep; 2009 Dec; 22(6):1435-41. PubMed ID: 19885597
    [Abstract] [Full Text] [Related]

  • 2. RNA interference-mediated depletion of phosphoinositide 3-kinase activates forkhead box class O transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells.
    Reagan-Shaw S, Ahmad N.
    Cancer Res; 2006 Jan 15; 66(2):1062-9. PubMed ID: 16424042
    [Abstract] [Full Text] [Related]

  • 3. [Influence of phosphatidylinositol-3-kinases P85α silence by RNA interference on cell cycle and apoptosis of colorectal cancer cells in vitro].
    Xu XH, Sun Y, Zeng H.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Mar 15; 14(3):206-9. PubMed ID: 21442486
    [Abstract] [Full Text] [Related]

  • 4. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH.
    Cell Signal; 2006 Dec 15; 18(12):2262-71. PubMed ID: 16839745
    [Abstract] [Full Text] [Related]

  • 5. [PI3K p85alpha gene silencing by RNA interference promotes 5-fluorouracil-induced apoptosis of colorectal cancer LoVo cells].
    Yang H, Ni L, Ma YQ, Song YG.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May 15; 30(5):1085-8. PubMed ID: 20501401
    [Abstract] [Full Text] [Related]

  • 6. The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
    Li CJ, Chang JK, Chou CH, Wang GJ, Ho ML.
    Biochem Pharmacol; 2010 Mar 15; 79(6):926-37. PubMed ID: 19883628
    [Abstract] [Full Text] [Related]

  • 7. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
    Cappellini A, Tabellini G, Zweyer M, Bortul R, Tazzari PL, Billi AM, Falà F, Cocco L, Martelli AM.
    Leukemia; 2003 Nov 15; 17(11):2157-67. PubMed ID: 12931221
    [Abstract] [Full Text] [Related]

  • 8. Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells.
    An HJ, Cho NH, Yang HS, Kwak KB, Kim NK, Oh DY, Lee SW, Kim HO, Koh JJ.
    J Pathol; 2007 Jun 15; 212(2):161-9. PubMed ID: 17427168
    [Abstract] [Full Text] [Related]

  • 9. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
    Evans-Anderson HJ, Alfieri CM, Yutzey KE.
    Circ Res; 2008 Mar 28; 102(6):686-94. PubMed ID: 18218983
    [Abstract] [Full Text] [Related]

  • 10. Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma.
    Rychahou PG, Jackson LN, Silva SR, Rajaraman S, Evers BM.
    Ann Surg; 2006 Jun 28; 243(6):833-42; discussion 843-4. PubMed ID: 16772787
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
    Abid MR, Guo S, Minami T, Spokes KC, Ueki K, Skurk C, Walsh K, Aird WC.
    Arterioscler Thromb Vasc Biol; 2004 Feb 28; 24(2):294-300. PubMed ID: 14656735
    [Abstract] [Full Text] [Related]

  • 12. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L, Glassford J, Lea NC, Thomas NS, Klaus GG, Lam EW.
    Oncogene; 2001 Nov 01; 20(50):7352-67. PubMed ID: 11704865
    [Abstract] [Full Text] [Related]

  • 13. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE, Busse D, Flanagan WM, Yakes FM, Arteaga CL.
    Cancer Res; 2001 Sep 01; 61(17):6583-91. PubMed ID: 11522658
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of silencing of PI3K p85α on 5-FU-induced colorectal cancer cells apoptosis.
    Sun Y, Tian H, Wang L, Yang H.
    Med Oncol; 2013 Dec 01; 30(4):704. PubMed ID: 23990352
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR.
    Belmont PJ, Jiang P, McKee TD, Xie T, Isaacson J, Baryla NE, Roper J, Sinnamon MJ, Lee NV, Kan JL, Guicherit O, Wouters BG, O'Brien CA, Shields D, Olson P, VanArsdale T, Weinrich SL, Rejto P, Christensen JG, Fantin VR, Hung KE, Martin ES.
    Sci Signal; 2014 Nov 11; 7(351):ra107. PubMed ID: 25389372
    [Abstract] [Full Text] [Related]

  • 20. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
    Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N.
    Cancer Res; 2008 Jul 01; 68(13):5076-85. PubMed ID: 18593906
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.